Dengue virus fever in USA: Over 9.7 million cases reported. Check symptoms, treatment

More than 9.7 million dengue cases have been reported so far in the US this year, an exponential spike from 4.6 million cases detected in 2023, USA Today reported citing data from the Centers for Disease Control and Prevention (CDC).

On Tuesday, the CDC issued a health advisory highlighting a rise in dengue virus infections this year, urging heightened awareness and preventive measures.

Also Read: Lanterns Series: Everything we know about production team, episode count, plot and characters


Dengue is transmitted to humans through mosquito bites. It is a viral disease caused by any of the four dengue virus. Each year, up to 400 million people worldwide are infected by this virus, making it a significant global health concern, the USA Today report says.

Dengue Symptoms

CDC has stated that one person out of 4 people infected by Dengue have the tendency to fall sick with a number of symptoms. These symptoms are fever, aches and pains, nausea, vomiting, rash, muscle and joint pain. Generally, these symptoms remain for two to seven days.

In some cases, it can cause a more severe hemorrhagic fever, resulting in bleeding that can lead to death.

Dengue Treatment

CDC has prescribed a dengue vaccine for patients. However, since prevention is better than cure, one can use insect repellent, long-sleeved shirts and pants and try to control mosquitoes.

Last month, the WHO "prequalified" Takeda Pharmaceuticals' dengue vaccine Qdenga, making it eligible for procurement by United Nations agencies such as UNICEF and Pan American Health Organization.

Also Read: Surge in plastic surgery in America: Here are the top procedures being followed

Qdenga is approved in the European Union and in Indonesia, Thailand, Argentina and Brazil, among others. French drugmaker Sanofi's Dengvaxia is also approved in several countries in the Americas, the EU and Asia.

FAQs:

Q1. What are Dengue Symptoms?
A1. CDC has stated that one person out of 4 people infected by Dengue have the tendency to fall sick with a number of symptoms. These symptoms are fever, aches and pains, nausea, vomiting, rash, muscle and joint pain. Generally, these symptoms remain for two to seven days.

Q2. What are dengue vaccines?
A2. Last month, the WHO "prequalified" Takeda Pharmaceuticals' dengue vaccine Qdenga, making it eligible for procurement by United Nations agencies such as UNICEF and Pan American Health Organization. Qdenga is approved in the European Union and in Indonesia, Thailand, Argentina and Brazil, among others. French drugmaker Sanofi's Dengvaxia is also approved in several countries in the Americas, the EU and Asia